Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 116 days ( 0 % )
Last Price $1.80 0 %
High/ Low $1.80 - $1.80 0%
Chg 7 Days N/A $1.80 $1.80
Chg 30 Days N/A $1.80 $1.80
Chg 12 mos -48.42 % $3.49 $1.80
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -57.00 % Width: 2,669.93 %
Pred. range - 3 mos $1.80 - $1.80 0 % - 0 %
Pred. range - 12 mos $0.0337 - $0.93 -98.13 % - -48.20 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Feb 16, 2022 - 126 days
Long MA avg 12 mos Sell Nov 10, 2021 - 193 days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Sell Aug 16, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About GTx

GTx GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of breast and prostate cancer, and other serious medical conditions. The company is developing selective androgen receptor modulators to treat a range of serious diseases, including breast cancer, stress urinary incontinence, and Duchenne muscular dystrophy; and selective androgen receptor degrader for the trea... GTXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT